SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial

Article English OPEN
Crabb, S.; Danson, S.J.; Catto, J.W.F.; McDowell, C.; Lowder, J.N.; Caddy, J.; Dunkley, D.; Rajaram, J.; Ellis, D.; Hill, S.; Hathorn, D.; Whitehead, A.; Kalevras, M.; Huddart, R.; Griffiths, G.;
(2018)

Background Urothelial bladder cancer (UBC) accounts for 10,000 new diagnoses and 5000 deaths annually in the UK (Cancer Research UK, http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bladder-cancer, Cancer Research UK, Acces... View more
Share - Bookmark